Our results in a large series of Mediterranean patients from a single reference center, together with those from other articles published on this topic, [1–8] indicate that anti-MDA5 antibodies may be a hallmark of adult CADM patients with RP-ILD regardless of their origin. The gene discussed is IFIH1; the disease is clinically amyopathic dermatomyositis.